PCN82 COST-EFFECTIVENESS OF NIVOLUMAB AS ADJUVANT TREATMENT...

Value in Health 2019 / 11 Vol. 22

PCN82 COST-EFFECTIVENESS OF NIVOLUMAB AS ADJUVANT TREATMENT OF MELANOMA IN ADULTS WITH INVOLVEMENT OF LYMPH NODES OR METASTATIC DISEASE WHO HAVE UNDERGONE COMPLETE RESECTION IN THE ITALIAN SETTING

Di Rienzo, P., Mennini, F.S., Marcellusi, A., Bini, C., Augusto, M., Orsini, I., Teitsson, S., Amadi, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.279
Date:
November, 2019
File:
PDF, 650 KB
2019
Conversion to is in progress
Conversion to is failed